home / stock / bwv / bwv news

BWV News and Press, Blue Water Vaccines Inc. From 01/17/23

Stock Information
Company Name: Blue Water Vaccines Inc.
Stock Symbol: BWV
Market: NASDAQ
Menu
BWV BWV Quote BWV Short BWV News BWV Articles BWV Message Board
Get BWV Alerts

News, Short Squeeze, Breakout and More Instantly...
BWV - Blue Water Vaccines Announces Appointment of Seasoned Public Market and Private Equity Investment Leader Timothy Ramdeen to Board of Directors

CINCINNATI, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced the...
BWV - Market Trends: Large Cap Equity

Summary US Large Cap stocks are still in a short-term downtrend but the long-term uptrend is intact. International Large Cap stocks are in a short-term uptrend versus US Large Cap. The trend has been driven by the falling dollar. US Large Cap value is in a short-term uptrend versus ...

BWV - Blue Water Vaccines to Present at Biotech Showcase 2023 During the 41st Annual J.P. Morgan Healthcare Conference Week in San Francisco

CINCINNATI, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced tha...

BWV - Yields Are Near 10-Year Highs Across Much Of The Bond Market

Summary For 40 years, steadily declining inflation and interest rates buoyed equity returns. That changed abruptly last year. Investors must now adjust expectations to a new macroeconomic and market landscape that will require a fresh mindset to reach long-term goals. By...
BWV - Blue Water Vaccines Announces Institutional Research Coverage by Two Notable Healthcare-Focused Wall Street Banks, Receives "Buy" Rating From Both

CINCINNATI, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced its...

BWV - Blue Water Vaccines Organizes Key Opinion Leader Event to Discuss Unmet Need for Acute Otitis Media and Pneumonia Vaccine and Its Streptococcus pneumoniae Vaccine Candidate

CINCINNATI, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”) a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced the ...

BWV - Blue Water Vaccines to Present Update on Novel, Live Attenuated, Intranasally Delivered Streptococcus pneumoniae Vaccine to Prevent Acute Otitis Media, Pneumococcal Pneumonia, and Invasive Pneumococcal Disease at the World Vaccine & Immunotherapy Congress

CINCINNATI, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), today announced that Ali Fattom, Ph.D., will present at the World Vaccine & Immunotherapy Congress West Coast 2022 in San Diego, ...
BWV - Blue Water Vaccines Announces Exclusive, Global License Agreement for Chlamydia Vaccine Candidate Development from The University of Texas Health San Antonio

CINCINNATI, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”) a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announce...

BWV - The 1-Minute Market Report November 10, 2022

Summary In today's issue of the 1-Minute Market Report, I examine the market bounce since the October low, and highlight the areas of the market that are leading the way higher. On Thursday, for every stock that was down, there were 26 that were up. For the first time since August...

BWV - Blue Water Vaccines GAAP EPS of -$0.27

Blue Water Vaccines press release ( NASDAQ: BWV ): Q3 GAAP EPS of -$0.27. Cash was $29.1 million as of September 30, 2022, as compared to $1.9 million as of December 31, 2021. For further details see: Blue Water Vaccines GAAP EPS of -$0.27

Previous 10 Next 10